FDA Adverse Event Malfunction Summary report: N

BD NEXIVA

MDR report key: 20894245 · Received December 10, 2024

Report

Report Number
1710034-2024-01461
Event Type
Malfunction
Date Received
December 10, 2024
Date of Event
August 27, 2024
Report Date
January 31, 2025
Manufacturer
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
Product Code
FOZ
UDI-DI
00382903835317
PMA / PMN Number
K183399
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
RISK MANAGER
Health Professional
N

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION RESULTS OF LATE PHOTO SAMPLE: THE COMPLAINT OF A DAMAGED EXTENSION TUBING WAS CONFIRMED; HOWEVER, THE ROOT CAUSE COULD NOT BE DETERMINED FROM THE THREE PHOTOGRAPHS THAT WERE PROVIDED FOR INVESTIGATION. ONE PHOTO SHOWED A 24G NEXIVA DEVICE WITH EVIDENCE OF USE. A TRANSPARENT DRESSING WAS OBSERVED ON THE DEVICE. THE NEEDLE HAD BEEN REMOVED FROM THE CATHETER AND WHAT APPEARED TO BE BLOOD RESIDUE WAS OBSERVED THROUGHOUT THE CATHETER AND EXTENSION TUBING. THE LUER ADAPTER WAS NOT CONNECTED TO THE END OF THE EXTENSION TUBE. IT COULD NOT BE DETERMINED IF THE TUBING WAS FRACTURED, CUT, OR INTACT. A REVIEW OF THE INSPECTION RECORDS AND QUALITY/MANUFACTURING CONTROLS FOR THE IMPLICATED LOT INDICATED NO ISSUES WITH THE MANUFACTURING PROCESS. MANUFACTURING CONTROLS ARE IN PLACE TO MITIGATE THE OCCURRENCE OF THIS TYPE OF FAILURE. THE COMPLAINT HAS BEEN DOCUMENTED AND WILL CONTINUE TO BE MONITORED AS PART OF ONGOING EFFORTS TO IDENTIFY POTENTIAL MANUFACTURING RELATED ISSUES. A REVIEW OF OUR RISK MANAGEMENT DOCUMENTATION WAS PERFORMED AND INDICATES THAT THE POTENTIAL RISK OF THE REPORTED EVENT WAS ASSESSED APPROPRIATELY.

Additional Manufacturer Narrative · 0

INVESTIGATION RESULTS: A DEVICE HISTORY RECORD REVIEW WAS COMPLETED BY OUR QUALITY ENGINEER TEAM FOR PROVIDED MATERIAL NUMBER 383531 AND LOT NUMBER 4120706. THE REVIEW DID NOT REVEAL ANY DETECTED ABNORMALITIES DURING THE PRODUCTION PROCESS THAT COULD HAVE CONTRIBUTED TO THIS DEFECT AND ALL QUALITY TESTS WERE FOUND TO BE WITHIN SPECIFICATION. AS A SAMPLE WAS UNAVAILABLE FOR RETURN, A THOROUGH SAMPLE INVESTIGATION COULD NOT BE COMPLETED. BASED ON THE INVESTIGATION RESULTS, AN EXACT CAUSE FOR THIS INCIDENT COULD NOT BE IDENTIFIED.

Additional Manufacturer Narrative · 0

H.3. A FOLLOW UP MDR WILL BE SUBMITTED IF ADDITIONAL INFORMATION, A DEVICE EVALUATION, OR A DEVICE HISTORY REVIEW IS COMPLETED.

Description of Event or Problem · 0

NO ADDITIONAL INFORMATION.

Description of Event or Problem · 0

NO ADDITIONAL INFORMATION.

Description of Event or Problem · 0

IT WAS REPORTED THAT BD NEXIVA CATHETER BROKE/DISCONNECTED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: SUCCESSFUL INTRAVENOUS LINE (IV) START, BUT THE CATHETER BROKE/DISCONNECTED. BLEEDING NOTED AND IV NO LONGER CLEAN OR INTACT; HAD TO RESTART/RE-POKE THE PATIENT. (B)(6). PATIENT HAD TO BE RE-STUCK. (B)(6)2024.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1419471 BD NEXIVA PERIPHERAL IV CATHETERS FOZ BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. 4120706 00382903835317

Patients

Seq Age Sex Outcome Treatment
1 72 YR Unknown